FLXN Flexion Therapeutics Inc

Flexion Therapeutics Inc is a development stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel, long-acting, injectable pain therapies including; anti-inflammatory and analgesic therapies.

$8.93  +0.07 (0.79%)
As of 06/23/2021 15:59:51 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2014
Outstanding shares:  49,942,069
Average volume:  515,740
Market cap:   $456,969,931
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    33938J106
ISIN:        US33938J1060
Sedol:      BJ36RM8
Valuation   (See tab for details)
PE ratio:   -4.20
PB ratio:   26.45
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy